1-3 of 3
Karolyn Oetjen, MD
Close
Sort by
Journal Articles

Pembrolizumab and Decitabine for Refractory or Relapsed Acute Myeloid Leukemia

Katherine E Lindblad, Julie Thompson, RN, Gege Gui, MS, Janet Valdez, Tatyana Worthy, Hanna Tekleab, Tom Hughes, Pharm.D., Meghali Goswami, BS, Karolyn Oetjen, MD, Dong-Yun Kim, PhD, Laura Dillon, PhD, Christin DeStefano, MD, Catherine E. Lai, MD, Christopher S. Hourigan, DPhil FACP FRCP
Journal: Blood
Blood (2018) 132 (Supplement 1): 1437.
https://doi.org/10.1182/blood-2018-99-115097
Published: 2018
Journal Articles

Neoantigen Landscape of Relapsed Acute Leukemia Following Allogeneic Stem Cell Transplantation

Karolyn Oetjen, MD, Cai Chen, Christian Bradley, BS, Reema Panjwani, BS, Cheng Yan, Minoo Battiwalla, MD, Pawel Muranski, MD, Austin John Barrett, Sawa Ito, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4595.
https://doi.org/10.1182/blood-2018-99-115501
Published: 2018
Journal Articles

Increased Frequencies of PD-1+ CD8+ Marrow-Infiltrating Lymphocytes Associated with Highly Clonal T-Lymphocyte Expansions in Relapsed and Refractory AML Patients but Not Healthy Adults

Meghali Goswami, Karolyn Oetjen, MD PhD, Matthew P. Mulé, BS, Sheenu Sheela, MBBS, Hong Yuen Wong, PhD, Qingguo Liu, MD, Katherine R. Calvo, MD PhD, Catherine E. Lai, MD, Christopher S. Hourigan, MD PhD
Journal: Blood
Blood (2016) 128 (22): 1644.
https://doi.org/10.1182/blood.V128.22.1644.1644
Published: 2016